Skip to Content

Hyperviscosity - newborn

Definition

Hyperviscosity of the newborn is the slowing and blockage of blood flow that results when there are too many red blood cells in an infant's blood.

Alternative Names

Neonatal polycythemia

Causes

Hyperviscosity can occur when the percentage of red blood cells (RBCs) in the infant's blood is greater than 65%. This may result from various conditions that develop before birth, such as:

  • Birth defects
  • Delay in clamping the umbilical cord
  • Inherited diseases
  • Not enough oxygen reaching body tissues (hypoxia)

The extra RBCs block the flow of blood in the smallest blood vessels. This leads to tissue death from lack of oxygen. This blocked blood flow can affect all organs, including the kidneys, lungs, and brain.

Symptoms

Symptoms may include:

Exams and Tests

There may be signs of breathing problems, kidney failure, and newborn jaundice.

If the baby has symptoms of hyperviscosity, a blood test to count the number of red blood cells will be done. This test is called a hematocrit.

Other tests may include:

  • Blood gases to check oxygen level in the blood
  • Blood sugar (glucose) to check for low blood sugar
  • Blood urea nitrogen (BUN), a substance that forms when protein breaks down
  • Creatinine, a substance produced by muscles that can build up in the blood if the kidneys aren't working properly
  • Urinalysis

Treatment

The baby will be monitored for complications of hyperviscosity. If needed, an exchange transfusion will be done to lower the amount of red blood cells that are moving through the baby's blood vessels.

Other treatment may include increasing body fluids.

Outlook (Prognosis)

The outlook is good for infants with mild hyperviscosity and those who receive treatment for severe hyperviscosity.

Some children may have mild changes in neurological development. Parents who believe their child may show any signs of developmental delay should contact their health care provider.

Possible Complications

Complications may include:

  • Death of intestinal tissue (necrotizing enterocolitis)
  • Decreased fine motor control
  • Kidney failure
  • Seizures
  • Strokes
Review Date: 9/26/2007
Reviewed By: Deirdre O’Reilly, MD, MPH, Neonatologist, Division of Newborn Medicine, Children’s Hospital Boston and Instructor in Pediatrics, Harvard Medical School, Boston, Massachusetts. Review Provided by VeriMed Healthcare Network.
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
adam.com

Disclaimer: The information contained in this website, and its associated websites, is provided as a benefit to the local community, and the Internet community in general; it does not constitute medical advice. We try to provide quality information, but we make no claims, promises or guarantees about the accuracy, completeness, or adequacy of the information contained in or linked to this website and its associated sites. As medical advice must be tailored to the specific circumstances of each patient and healthcare is constantly changing, nothing provided herein should be used as a substitute for the advice of a competent physician. Furthermore, in providing this service, Adventist HealthCare does not condone or support all of the content covered in this site. As an Adventist health care organization, Adventist HealthCare acts in accordance with the ethical and religious directives for Adventist health care services.

Adventist HealthCare · 301-315-3030 · 1801 Research BLVD, Suite 400, Rockville, MD 20850

Submit an Online Information Request